Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of Neoadjuvant ADI-PEG 20 in Combination With Ifosfamide and Radiotherapy in Soft Tissue Sarcoma (STS)

NCT05813327 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05813327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05813327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of Neoadjuvant ADI-PEG 20 in Combination With Ifosfamide and Radiotherapy in Soft Tissue Sarcoma (STS)
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
March 14, 2024
Completion date
July 22, 2026
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma,soft tissue, soft tissue sarcoma, sts